Cargando…

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report

We report two cases of patients who developed severe adverse drug reactions including persistent movement disorders, nausea, and vertigo during treatment with quetiapine at maximum daily doses ranging between 300 and 400 mg. The extensive hepatic metabolism of quetiapine is mainly attributed to cyto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stäuble, Céline K., Lampert, Markus L., Mikoteit, Thorsten, Hatzinger, Martin, Hersberger, Kurt E., Meyer zu Schwabedissen, Henriette E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233787/ https://www.ncbi.nlm.nih.gov/pubmed/34204223 http://dx.doi.org/10.3390/ijms22126480

Ejemplares similares

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial
por: Stäuble, Céline K., et al.
Publicado: (2021)

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene
por: Stäuble, Céline K., et al.
Publicado: (2022)

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
por: Jeiziner, Chiara, et al.
Publicado: (2021)

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
por: Stäuble, Céline K., et al.
Publicado: (2022)

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
por: Bollinger, Anna, et al.
Publicado: (2023)

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept
por: Stäuble, Céline K., et al.
Publicado: (2021)

HLA‐associated adverse drug reactions ‐ scoping review
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy
por: Wiss, Florine M., et al.
Publicado: (2023)

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
por: Jeiziner, Chiara, et al.
Publicado: (2022)

Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service
por: Jeiziner, Chiara, et al.
Publicado: (2023)

Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report
por: Meyer zu Schwabedissen, Henriette E, et al.
Publicado: (2014)

Issues around the Prescription of Half Tablets in Northern Switzerland: The Irrational Case of Quetiapine
por: Allemann, Samuel S., et al.
Publicado: (2015)

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals
por: Schmid, Yasmin, et al.
Publicado: (2016)

Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2
por: Bachmann, Fabio, et al.
Publicado: (2021)

Expression and Function of Organic Anion Transporting Polypeptides in the Human Brain: Physiological and Pharmacological Implications
por: Schäfer, Anima M., et al.
Publicado: (2021)

Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics
por: Zubiaur, Pablo, et al.
Publicado: (2021)

No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA
por: Vizeli, Patrick, et al.
Publicado: (2017)

Pharmaceutical Discharge Management: Implementation in Swiss Hospitals Compared to International Guidelines
por: Studer, Helene, et al.
Publicado: (2021)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?
por: Studer, Helene, et al.
Publicado: (2020)

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
por: Kaufmann, Carole P, et al.
Publicado: (2015)

Clinical relevance of St. John's wort drug interactions revisited
por: Nicolussi, Simon, et al.
Publicado: (2020)

Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4‐methylaminoantipyrine
por: Bachmann, Fabio, et al.
Publicado: (2021)

Having versus not having social interactions in patients diagnosed with depression or social phobia and controls
por: Villanueva, Jeanette, et al.
Publicado: (2021)

Various effects of repeated rifampin dosing on coproporphyrin levels in humans
por: Kinzi, Jonny, et al.
Publicado: (2023)

Well-being in major depression and social phobia with and without comorbidity
por: Wersebe, Hanna, et al.
Publicado: (2018)

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems
por: Kaufmann, Carole P, et al.
Publicado: (2018)

PDMS-PMOXA-Nanoparticles Featuring a Cathepsin B-Triggered Release Mechanism
por: Ehrsam, Daniel, et al.
Publicado: (2019)

Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Dose-Dependent Biphasic Action of Quetiapine on AMPK Signalling via 5-HT7 Receptor: Exploring Pathophysiology of Clinical and Adverse Effects of Quetiapine
por: Okada, Motohiro, et al.
Publicado: (2022)

Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008)

Cross-reaction of angioedema with clozapine, olanzapine, and quetiapine: A case report
por: Williams, Gabriela D.
Publicado: (2019)

Development of the Swiss Database for dosing medicinal products in pediatrics
por: Tilen, Romy, et al.
Publicado: (2021)

Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta
por: Taggi, Valerio, et al.
Publicado: (2022)

Post-Event Processing After Embarrassing Situations: Comparing Experience Sampling Data of Depressed and Socially Anxious Individuals
por: Čolić, Jasmin, et al.
Publicado: (2020)

Needs monitoring with quetiapine
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Cortisol Impacted on Explicit Learning Encoding, but Not on Storage and Retrieval, and Was Not Associated With Sleep Patterns—Results From the Trier Social Stress Test for Children (TSST-C) Among 9-Years Old Children
por: Brand, Serge, et al.
Publicado: (2018)

Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin‐Induced Cutaneous Adverse Drug Reactions
por: Fohner, Alison E., et al.
Publicado: (2020)

Adverse events with quetiapine and clarithromycin coprescription: A population‐based retrospective cohort study
por: Yau, Kevin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bnn6o4mmd1k1r1993a8ucibrl5